Primary thyroid malignancies in Tehran, Iran

Medical Principles and Practice

Volumn 14, Issue 6, 2005, Pages 396-400

  Larijani, Bagher ^a,d   Mohagheghi, Mohammad Ali ^b   Bastanhagh, Mohammad Hassan ^a   Mosavi Jarrahi, Ali Reza ^b,c   Haghpanah, Vahid ^a   Tavangar, Seyed Mohammad ^d   Bandarian, Fatemeh ^a   Khaleghian, Nasim ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer registry; Epidemiology; Survival; Thyroid cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER REGISTRY; CANCER SURVIVAL; CONFIDENCE INTERVAL; FAMILY; FEMALE; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MORTALITY; POPULATION; STATISTICS; SURVIVAL RATE; SURVIVAL TIME; TELEPHONE; THYROID CANCER; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 26644466111     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088112     Document Type: Article

References (28)

1. Franceschi S, La Vecchia C: Cancer of the thyroid; in Doll RI, Fraumeni JF Jr, Muir CS (eds): Trends in Cancer Incidence and Mortality. Cold Spring Harbor, Cold Spring Harbor Press, 1994, pp 393-424.
2. Franceschi S, Preston-Martin S, Dal Maso L, et al: A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583-595.
3. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J: Cancer Incidence in Five Continents. Lyon, IARC, 1992, pp 146-147.
4. Mulla ZD, Margo CE: Primary malignancies of the thyroid: epidemiological analysis of the Florida cancer data system registry. Ann Epidemiol 2000;10:24-30.
5. Christensen SB, Ljundberg O, Tibblin S: Thyroid carcinoma in Maloma, 1960-1977. Cancer 1984;53:1625-1633.
6. Ain KB: Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1995;24:711-760.
7. Ferich L, Akslen LA, Glattre E: Increased risk of thyroid cancer among Norwegian women married to fishery workers: a retrospective cohort study. Br J Cancer 1997;76:385-389.
8. Galanti MR, Ekbom A, Grimelius L, Yuen J: Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997;75:451-456.
9. Salabe GB: Aetiology of thyroid cancer and epidemiological overview. Thyrology 1994;6:11-19.
10. Kimiagar M, Azizi F, Navai L, Yassai M, Nafarabadi T: Survey of iodine deficiency in a rural area near Tehran: association of food intake and endemic goiter. Eur J Clin Nutr 1990;44:17-22.
11. Azizi F, Kimiagar M, Nafarabadi M: Current state of iodine deficiency in the Islamic Republic of Iran. EMR Health Survey 1990;8:23-27.
12. Larijani B, Shirzad M, Mohagheghi MA, Haghpanah V, Mosavi-Jarrahi AR, Tavangar SM, Vassigh AR, Hossein-Nezhad A, Bandarian F, Jalili RB: Epidemiologic analysis of the Tehran Cancer Institute Data System Registry (TCIDSR). Asian Pac J Cancer Prev 2004;5:36-39.
13. Mohagheghi M, Moosavi JA, Shariat TS: Annual report of Tehran University of Medical Sciences District Cancer Registry. Tehran, 1998.
14. Mosavi-Jarrahi A, Mohagheghi MA, Atri M, Golmahi M: Developing best sets of information recorded in cancer registry database to search for duplicate and repeat management; in 23rd Annu Meet Int Assoc Cancer Registries, Havana, Oct 2001.
15. Al Jarallah M, Al Hamdan N: Gulf Center for Cancer Registration (GCCR). 2000 cancer incidence report. Riyadh, GCCR, 2003.
16. McCredie M, Coates M, Grulich A, Grulich A: Cancer incidence in migrants to New South Wales (Australia) from the Middle East, 1972-1991. Cancer Causes Control 1995;5:414-421.
17. Azizi F, Navai L, Navai L, Fattahi F: Goiter prevalence, urinary iodine excretion, thyroid function and anti-thyroid function and anti-thyroid antibodies after 12 years of salt iodization in Shahriar, Iran. Int J Vitam Nutr Res 2002;72:291-295.
18. Franceschi S, Fassina A, Talamini R, Mazzolini A, Vianello S, Bidoli E, Serraino D, La Vecchia C: Risk factors for thyroid cancer in North Italy. Int J Epidemiol 1989;18:578-584.
19. Franssila K, Saxen E, Teppo L, Bjarnason O, Tulinius H, Normann T, Ringertz N: Incidence of different morphological types of thyroid in Nordic countries. APMS 1981;89:49-55.
20. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R: Incidence and characteristic of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 1997;7:733-741.
21. 226Ra from consumption of vegetable in high level natural radiation areas of Ramsar, Iran. J Environ Radioact 2003;66:215-225.
22. Mohammadi H, Tabeie F, Saghari M: Trends of population radiation absorbed dose from diagnostic nuclear medicine procedures in Iran: 1985-1989. Health Phys 1995;68:503-508.
23. Tavakoli MB: Annual radiation background in the City of Isfahan. Med Sci Monit 2003;9:PH7-PH10.
24. Ron E: Thyroid cancer; in Schottenfield D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, ed 2. New York, Oxford University Press, 1996.
25. Tronko MD, Bogdanova TI, Komissarenko IV, Epstein OV, Oliynyk V, Kovalenko A, Likhtarev IA, Kairo I: Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accidents: statistical data and clinicomorphologic characteristics. Cancer 1999;86:149-156.
26. Sankaranarayanan R, Black RJ, Parkin DM: Cancer Survival in Developing Countries. Lyon, International Agency for Research on Cancer, publication No 145, 1998.
27. Ries LAG, Miller BA, Hanky BF: SEER Cancer Statistics Review 1973-1991: tables and graphs. Bethesda, National Cancer Institute, publication No 94-2789.
28. Larijani B, Aghakhani S, Khajedini H, Baradar-Jalili R: Clinico-pathological features of thyroid cancer as observed in five referral hospitals in Iran; a review of 1,177 cases. Acta Oncol 2003;42:334-337.